Compugen (CGEN) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Compugen (CGEN) PT Lowered to $14 at Truist Securities
February 25, 2022 6:36 AM ESTTruist Securities analyst Asthika Goonewardene lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Following the EPS call and our discussion with mgmt, we are adjusting our model to reflect a slower route... More
Compugen (CGEN) PT Lowered to $14 at Stifel
February 24, 2022 12:17 PM ESTStifel analyst Stephen Willey lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Management continues to make progress on the various dose expansion cohorts comprising the P1/2 development program evaluating various COM701-based combinations... More



